With the use of established cell surface markers (CD19, and CD7 for B- and T-ALL, THY-1 for MSC and CDH5 for HUVEC) for their identification, both supporting and leukemic cells were analyzed by clusters. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.